Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair.

Clin Cancer Res · 2023 · PMC10644001 · PMID 37725585

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

We found a clear trend toward enhanced synergism in drug-resistant cells in the case of entinostat combined with epirubicin, irinotecan, and carboplatin (Supplementary Fig.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.